<span id="midArticle_start"/>(Adds headline)
<span id="midArticle_0"/>May 4 (Reuters) - Bayer Ag
<span id="midArticle_1"/>* Bayer news release: not intended for U.S. and UK media -Bayer'S Xarelto approved in China for stroke prevention inpatients with non-valvular atrial fibrillation and for thetreatment of deep vein thrombosisFurther company coverage:
<span id="midArticle_2"/>
<span id="midArticle_0"/>May 4 (Reuters) - Bayer Ag
<span id="midArticle_1"/>* Bayer news release: not intended for U.S. and UK media -Bayer'S Xarelto approved in China for stroke prevention inpatients with non-valvular atrial fibrillation and for thetreatment of deep vein thrombosisFurther company coverage:
<span id="midArticle_2"/>
via Smart Health Shop Forum http://ift.tt/1K66zGz
No comments:
Post a Comment